BioCryst Pharmaceuticals
Durham, North Carolina, United States · Biotechnology, Health Care, Therapeutics
BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Durham, North Carolina, United States
- Employees
- 440
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Public (BCRX)
- Website
- http://www.biocryst.com/
- Company page
Recent activity at BioCryst Pharmaceuticals
- : BioCryst acquires Astria Therapeutics for drug access
- : SEC 8-K (7.01):
- : SEC 8-K (7.01):
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Employee benefit plans
BioCryst Pharmaceuticals files 3 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About BioCryst Pharmaceuticals: questions and answers
What does BioCryst Pharmaceuticals do?
BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.
Where is BioCryst Pharmaceuticals headquartered?
BioCryst Pharmaceuticals is headquartered in Durham, North Carolina, United States.
How many employees does BioCryst Pharmaceuticals have?
BioCryst Pharmaceuticals has about 440 employees.
What is the latest news on BioCryst Pharmaceuticals?
On Aug 29, 2026, BioCryst acquires Astria Therapeutics for drug access
Is BioCryst Pharmaceuticals a public company?
Yes. BioCryst Pharmaceuticals is publicly traded under the ticker BCRX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy